<SEC-DOCUMENT>0001193125-24-133148.txt : 20240507
<SEC-HEADER>0001193125-24-133148.hdr.sgml : 20240507
<ACCEPTANCE-DATETIME>20240507162131
ACCESSION NUMBER:		0001193125-24-133148
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240507
FILED AS OF DATE:		20240507
DATE AS OF CHANGE:		20240507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANULIFE FINANCIAL CORP
		CENTRAL INDEX KEY:			0001086888
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				889897526
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14942
		FILM NUMBER:		24922307

	BUSINESS ADDRESS:	
		STREET 1:		200 BLOOR ST EAST, NT-10
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W1E5
		BUSINESS PHONE:		416-926-3000

	MAIL ADDRESS:	
		STREET 1:		200 BLOOR ST EAST, NT-10
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4W1E5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d803346d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of <U>May, 2024</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">1-14942</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MANULIFE FINANCIAL CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>200 Bloor
Street East </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>North Tower 10 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Toronto, Ontario, Canada M4W 1E5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(416) <FONT STYLE="white-space:nowrap">926-3000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form <FONT STYLE="white-space:nowrap">20-F&#8194;&#9744;&#8195;&#8195;&#8195;Form</FONT>
<FONT STYLE="white-space:nowrap">40-F&#8194;&#9745;</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DOCUMENTS FILED AS PART OF THIS FORM <FONT STYLE="white-space:nowrap">6-K</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents, filed as exhibits to this Form <FONT STYLE="white-space:nowrap">6-K,</FONT> are incorporated by reference as part of
this Form <FONT STYLE="white-space:nowrap">6-K:</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">News release dated May 7, 2024 announcing that Manulife Amends its Normal Course Issuer Bid to Repurchase for Cancellation up to an Additional 40 Million of its Common Shares</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MANULIFE FINANCIAL CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><I>/s/ Scott MacIntosh</I></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Scott MacIntosh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Assistant Corporate Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May 7, 2024 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d803346dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g803346dsp3.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:26pt; font-family:ARIAL"><B>News </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:26pt; font-family:ARIAL"><B>Release </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:ARIAL">C$ unless otherwise stated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:ARIAL">TSX/NYSE/PSE: MFC&#8195; SEHK: 945</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">For Immediate Release </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL">May&nbsp;7, 2024 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; line-height:20.0pt; font-size:12pt; font-family:ARIAL"><B>Manulife Amends its Normal Course Issuer Bid to Repurchase for Cancellation up to an Additional 40 Million of its Common Shares </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">TORONTO &#150; Manulife Financial Corporation (&#147;Manulife&#148;) announced today that the Toronto Stock Exchange (&#147;TSX&#148;) has approved
Manulife&#146;s amended normal course issuer bid (&#147;NCIB&#148;). As previously announced, the purpose of the amendment is to increase the number of common shares that Manulife may repurchase from up to 50&nbsp;million (approximately 2.8% of
shares outstanding) to up to 90&nbsp;million (approximately 5% of shares outstanding as of February 12, 2024). The amendment is effective as of May&nbsp;13, 2024. The Office of the Superintendent of Financial Institutions previously approved the
amended NCIB. Since the commencement of its current NCIB on February&nbsp;23, 2024 to May&nbsp;3, 2024, Manulife has completed the repurchase for cancellation of 12,390,400 common shares at a volume weighted average repurchase price per common share
of $32.55. Under the NCIB, Manulife may purchase up to 1,521,140 of its common shares on the TSX during any trading day, which represents 25% of the average daily trading volume of 6,084,560&nbsp;common shares on the TSX for the six months
ended&nbsp;January&nbsp;31, 2024, subject to TSX rules permitting block purchases. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Continuing to have an NCIB in place will provide Manulife with
the flexibility to purchase common shares as part of its capital management strategy which is designed to maintain healthy regulatory capital ratios while balancing the objective of generating shareholder value. In addition, Manulife intends to
repurchase shares in order to mitigate the impact on diluted Earnings Per Share and core Earnings Per Share from previously announced reinsurance transactions, one of which closed in February 2024 and the second of which closed in April 2024. The
actual number of common shares purchased, the timing of such purchases and the price at which common shares are purchased will be determined by Manulife. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Manulife&#146;s current normal course issuer bid commenced on February&nbsp;23, 2024 and will
continue until February&nbsp;22, 2025, when the NCIB expires, or such earlier date as Manulife completes its purchases. Purchases under the NCIB may be made through the facilities of the TSX, the New York Stock Exchange, and alternative trading
systems in Canada and the United States at market prices prevailing at the time of purchase or such other price as may be permitted. All common shares acquired by Manulife under the NCIB will be cancelled. Repurchases will be subject to compliance
with applicable Canadian securities laws and United States federal securities laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">In addition, Manulife may undertake repurchases of its common
shares outside of Canada and the United States in compliance with applicable laws. Subject to regulatory approval, Manulife may also acquire common shares directly from other holders by way of private agreement pursuant to issuer bid exemption
orders issued by applicable securities regulatory authorities. Any private purchase made under an exemption order issued by a securities regulatory authority will generally be at a discount to the prevailing market price. Manulife may also enter
into derivative-based programs in support of its repurchase activities, including the writing of put options and forward purchase agreements, accelerated share repurchase transactions, other equity contracts or use other methods of acquiring shares,
in each case subject to regulatory approval and on such terms and at such times as shall be permitted by applicable securities laws. The total number of common shares repurchased under the NCIB and all other potential arrangements will not exceed
90&nbsp;million common shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Manulife previously entered into an automatic share repurchase plan under which its designated broker will
repurchase Manulife&#146;s common shares pursuant to the NCIB, and the automatic plan, as will be amended to account for the aforementioned share increase, will continue to apply to the amended NCIB. The actual number of common shares purchased
under the automatic plan, the timing of such purchases and the price at which common shares are purchased will depend upon future market conditions. The automatic plan, which was <FONT STYLE="white-space:nowrap">pre-cleared</FONT> by the TSX,
provides for the potential repurchase of common shares at any time, including when Manulife ordinarily would not be active in the market due to its own internal trading blackout periods, insider trading rules, or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>Caution regarding forward-looking statements </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">This
document contains forward-looking statements within the meaning of the &#147;safe harbour&#148; provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995 with respect to possible future purchases
by Manulife of its common shares. Although we </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">
believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such
statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual common share
repurchases to differ materially from expectations include but are not limited to the fact that the amount and timing of any future common share repurchases will depend on the earnings, cash requirements and financial condition of Manulife, market
conditions, capital requirements (including under LICAT capital standards), common share issuance requirements, applicable law and regulations (including Canadian and U.S. securities laws and Canadian insurance company regulations), and other
factors deemed relevant by Manulife, and may be subject to regulatory approval or conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Additional information about material risk factors
that could cause actual results to differ materially from expectations may be found in our most recent annual and interim reports and elsewhere in our filings with Canadian and U.S. securities regulators. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof. We do not undertake to update any
forward-looking statements, except as required by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><B>About Manulife </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Manulife Financial Corporation is a leading international financial services provider, helping people make their decisions easier and lives better.
With our global headquarters in Toronto, Canada, we provide financial advice and insurance, operating as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States. Through Manulife Investment Management, the global
brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2023, we had more than 38,000 employees, over 98,000 agents, and thousands of distribution partners,
serving over 35 million customers. We trade as &#145;MFC&#146; on the Toronto, New York, and the Philippine stock exchanges, and under &#145;945&#146; in Hong Kong. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; line-height:20pt; font-size:11pt; font-family:ARIAL">Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="59%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Media Contact</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e">Cheryl Holmes</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e">Manulife</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-557-0945</FONT></FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL"><B>cheryl_holmes@manulife.com</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B>Investor Relations</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e">Hung Ko</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e">Manulife</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-806-9921</FONT></FONT></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#282b3e"><B>hung_ko@manulife.com</B></FONT></P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g803346dsp3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g803346dsp3.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M_=6MQ<Q^8UJQ:,'H">^/PH:3"I0A4E&4U>VQ=IFP4 % " !1@  >U  0",$
MCWH 1XXY$V.BLOHPR* %"J,84#' XZ4   7H /I0 !5 P  * &K#%&FQ(U5<
LYP!@4 .P,YP,^M  % S@ 9ZT   48  'M0 T0Q"0R"-1(>K8Y_.@!] '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
